Anuh Pharma Intrinsic Value
Anuh Pharma (ANUHPHR) median intrinsic value is ₹96.80 from 10 valuation models (range ₹28–₹187), vs current price ₹93.48 — +3.6% upside (Trading Near Calculated Value), margin of safety 3.4%. See ANUHPHR book value comparison to compare market price against book value per share.
ANUHPHR Valuation Methods Summary — DCF, Graham Number & P/E
Anuh Pharma intrinsic value across 10 models vs current price ₹93.48 — upside/downside and value range per method. For current market price and key ratios, visit ANUHPHR share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹96.80 | ₹77.44 - ₹116.16 | +3.6% | EPS: ₹4.40, Sector P/E: 22x |
| Book Value Method | asset | ₹140.80 | ₹126.72 - ₹154.88 | +50.6% | Book Value/Share: ₹70.40, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹186.96 | ₹168.26 - ₹205.66 | +100.0% | Revenue/Share: ₹156.80, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹144.00 | ₹129.60 - ₹158.40 | +54.0% | EBITDA: ₹72.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹78.54 | ₹62.83 - ₹94.25 | -16.0% | CF Growth: 8.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹28.16 | ₹25.34 - ₹30.98 | -69.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹69.33 | ₹62.40 - ₹76.26 | -25.8% | Revenue Growth: 10.1%, Adj P/E: 15.8x |
| ROE Based Valuation | profitability | ₹105.60 | ₹95.04 - ₹116.16 | +13.0% | ROE: 12.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹83.48 | ₹75.13 - ₹91.83 | -10.7% | EPS: ₹4.40, BVPS: ₹70.40 |
| Dividend Yield Method | dividend | ₹60.00 | ₹54.00 - ₹66.00 | -35.8% | DPS: ₹1.50, Target Yield: 2.5% |
ANUHPHR Intrinsic Value vs Market Price — All Valuation Models
Anuh Pharma fair value range ₹28–₹187 vs current market price ₹93.48 across 10 valuation models. Check ANUHPHR market value to track the company's total market size over time.
ANUHPHR Intrinsic Value Analysis — Undervalued or Overvalued?
Anuh Pharma median intrinsic value ₹96.80, current price ₹93.48 — Trading Near Calculated Value by 3.6%, margin of safety 3.4%.
What is the intrinsic value of ANUHPHR?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Anuh Pharma (ANUHPHR) is ₹96.80 (median value). With the current market price of ₹93.48, this represents a +3.6% variance from our estimated fair value.
The valuation range spans from ₹28.16 to ₹186.96, indicating ₹28.16 - ₹186.96.
Is ANUHPHR undervalued or overvalued?
Based on our multi-method analysis, Anuh Pharma (ANUHPHR) appears to be trading near calculated value by approximately 3.6%.
ANUHPHR Financial Health — Key Ratios vs Industry Benchmarks
Anuh Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 225.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.41x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ANUHPHR Cash Flow Quality — Operating & Free Cash Flow
Anuh Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹37 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹13 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹54 Cr | ₹32 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹29 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |